chrisvoncsefalvay/vaers-outcomes huggingface dataset:
METALLIC TASTE IN MOUTH; HIGH BLOOD GLUCOSE LEVEL; SLIGHT HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 09-MAR-2021 11:45 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-MAR-2021, the subject experienced metallic taste in mouth. On 09-MAR-2021, the subject experienced high blood glucose level. On 09-MAR-2021, the subject experienced slight headache. On 09-MAR-2021 12:50, Laboratory data included: Blood glucose (NR: not provided) 243 mg/dL. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the metallic taste in mouth, slight headache and high blood glucose level was not reported. This report was non-serious.
Patient reported to pharmacy 2 weeks post vaccine administration. Patient stated in significant pain at site of administration. Both arms hurt, but the right arm hurt significantly more than the left and had limited range of motion.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. There was no concurrent condition, medical history or concomitant medication reported. The pharmacist stated, that an unspecified female patient was vaccinated with the first dose of GARDSAIL (batch #; lot #, dose and route of administration were not reported) on an unspecified date in November 2012. The patient received the second and third doses of GARDASIL (batch #; lot #, dose and route of administration were not reported) on an unspecified date in January 2015, and on an unspecified date in February 2015, respectively. No adverse effect was reported. PQC (product quality complaint) was not involved. Additional information has been requested.
2/22/2023 woke up with a scratchy throat. The throat felt different and I got an odd feeling in my chest as well.  By 3 PM I got a tickle in my throat and developed a cough.  By 5 PM when I coughed I felt my airways closed off.  This got worse as the night went by.  I went to the ER early in the morning of 2/23/2023.  In ER the PCR COVID-19 test was positive.  I received a steroid injection, Prednisone, Zinc, Paxlovid, and a Zpak.  I went home and slept the rest of the day and woke up the next day and took the medications.  Symptoms gradually got better over the next 6 days.  The cough lingered for a few days and fatigue lingered about a month.
Allergic reaction to the first two vaccines; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An elderly female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Allergic reaction to the first two vaccines".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300154689 same patient/drug/AE, different dose;
No adverse effect reported; inadvertently vaccinated with an expired dose of Rotavirus Vaccine, Live, Oral, Pentavalent ((ROTATEQ); This spontaneous report was received from a medical assistant and refers to a 6 months old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications.  On 15-MAY-2019, the patient was inadvertently vaccinated with an expired dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) per oral route for prophylaxis, lot number N034400, expiration date 10-MAY-2019 (strength and dose number were not reported).  No adverse effects were reported.
Patient received booster of moderna (third dose of moderna total) and experienced a delayed onset uticaria reaction systemic in nature.  Patient self described painful and extremely itchy. Swelling was observed on unilateral foot and eye lid.  Uticaria eruption present on neck arms legs chest under breasts  Lot number 031821A  Treated with oral fexofenadine 180 mg BID and famotidine 20 mg BID topical corticosteroids and ice
Post rabies exposure (day 7), vaccine #3, Patient called office complained of headache, nausea, vomiting, abdominal pain, back pain, myalgia, malaise, chills, dizziness, numbness and timgling of extremities, tary stool.  Patient offer ESO visit and come to office.  Temp 101, Pulse 120-irregular BP 128/80, and restless legs.  Evaluated by MD.  Patient to emergency room for evaluation and treatment.  Note patient reported local swelling and rash to site of immunization, glaubin rash on 04/21/2003.
pt recv vax 1APR97 & the following day pt exp squishy, red & inj site to elbow, non-tend, warm 11x10cm in size, celluitis;
Heavy and painful period. I keep very close track of my period and usually I have moderate bleeding day one, cramps for 8 or so hours on day one, and then all uncomfortable symptoms go away by day 2 with very little bleeding day 2-4. This time, I have cramps for 48 hours and very heavy bleeding for 48 hours. During my period I was nauseous off and on, lightheaded most days and extremely fatigued the first two days enough so I couldn't work or get out of bed. This is all very different from my usual menstrual period and nothing changed in my diet or lifestyle from the previous month other than receiving this vaccine.
headache; feeling warm; This is a spontaneous report received from a contactable reporter(Consumer) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 29Mar2021 (Batch/Lot number: unknown) as dose 1, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious) with onset 18Apr2021, outcome "unknown", described as "headache"; FEELING HOT (non-serious) with onset 18Apr2021, outcome "unknown", described as "feeling warm". Additional Information: Patient was asking if she can take the vaccine on another day because tomorrow is her schedule to take the 2nd dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
16 year old inadvertently received Modern COVID-19 vaccine; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old inadvertently received Modern COVID-19 vaccine) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old inadvertently received Modern COVID-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old inadvertently received Modern COVID-19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment information was not provided.
I developed a hard, raised red bump on the front of my left shoulder the day that I had been vaccinated. I received the injection on the side of my left shoulder. The redness has spread on my upper arm  over the course of the last 5 days. It isn?t painful but does itch. This morning I had a phone visit with my doctor who advised me to take Advil three times a day for 3 days and call back if it continues to spread further.
Novina presented with rapid eye blinking and twitching of the muscles surrounding the eyes a few days after receiving vaccines. Both eyes are affected. She has multiple episodes daily, some very pronounced.
Blood clot in her leg; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (Blood clot in her leg) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (Blood clot in her leg) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (Blood clot in her leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication details were provided.  No Treatment medication details were provided.  Company comment: This case concerns a female patient with uknown age with no reported medical history, who experienced Serious , Unexpected event of Thrombosis , which occurred on  unknown date with an unknown dose number of mRNA-1273 Vaccine ( Moderna Covid 19 Vaccine ) The re-challenge for this case is not applicable. The benefit-risk relationship of mRNA-1273 vaccine (Moderna Covid 19 vaccine ) is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 09-Nov-2021: Non-significant follow-up document received on 10-Nov-2021, Reporter contact info updated.; Sender's Comments: This case concerns a female patient with uknown age with no reported medical history, who experienced Serious , Unexpected event of Thrombosis , which occurred on  unknown date with an unknown dose number of mRNA-1273 Vaccine ( Moderna Covid 19 Vaccine ) The re-challenge for this case is not applicable. The benefit-risk relationship of mRNA-1273 vaccine (Moderna Covid 19 vaccine ) is not affected by this report.
Syncopal episode. Resolved with supine posturing and hydration. Happened few minutes w/in 5 minutes of having vaccine.
Although I have had joint issues in both knees and hips. My right knee and hip had not given me any problems for several years.  While working at about 2:00 in the morning both my right hip and knee started to hurt.  I had been setting at a desk and no reason for the sudden pain.  It continued to get worse through the night  and all day today.  The pain in the joints is extreme.  I can barely walk.  I have taken an old meloxicam I had and some Tylenol extra strength.  I called and have an appointment with an orthopedic MD next Friday.  This is my 3rd shot and I have not experienced any thing like this on the first two.  I have had some left knee issues over the last couple of months but did not associate that with the timing  of my other vaccines.  This came on suddenly and severely with no explanation.  I would not have connected this if there was any other reasonable possibility.  I searched the internet and found that there had been a few cases. So I thought I should report it.
Shingles outbreak on same side as vaccine administration. The last outbreak of shingles I had was approximately 5 years ago.
Fever; Chills; Severe sweating (needed to change clothes); Intense headache that was almost a migraine; Intense headache that was almost a migraine; Frequent urination; 9/10 scale pain on the injection site and in underarm.; 9/10 scale pain on the injection site and in underarm; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 26-year-old female patient received bnt162b2 (BNT162B2 Formulation: Solution for injection), dose 3 via an unspecified route of administration on 21Oct2021 (Batch/Lot number was not reported) as DOSE 3, (BOOSTER), SINGLE (at the age of 26-year-old) for covid-19 immunisation. It was unknown if patient was not pregnant at the time of vaccination or not. The patient did not have any medical history and known allergies. Concomitant medications were not reported. The patient did not have Covid prior vaccination. Historical vaccine included first dose of bnt162b2 on 08Jan2021 and second dose of bnt162b2 on 29Jan2021 (Batch/Lot No: Unknown. Misplaced/discarded) (at the age of 25-year-old) for covid-19 immunisation. The patient experienced severe sweating (needed to change clothes), Intense headache that was almost a migraine, frequent urination, 9/10 scale pain on the injection site and in underarm, Chills and fever on 21Oct2021. The patient not tested for Covid post vaccination. It was unknown if treatment received for events fever and chills and for other events no treatment received. It was reported that all symptoms latest for 3 days. The outcome of events reported as recovered on an unknown date of 2021.   Follow-up attempts completed. No further information expected.
Patient received Varicella 0.5mL SQ injection on 1/28/16 (recommended by reproductive endocrinologist prior to pregnancy) and developed a tennis ball-sized redness/swollen area around injection site that was warm to the touch. Provider notified - reaction resolved with ice, BENADRYL and ADVIL over next few days per patient.
2/18/2023 I started getting a head cold, didn?t feel bad. It progressed into a sinus infection.  I went to an urgent care and I was prescribed Amoxicillin ? Potassium Clavulanate and began taking it. I am feeling pretty good now.
15SEP92 pt recvd vax & 18SEP92 devel swollen glands & sore throat; no treatment required;
left hip pain; Pain in left leg is still there /Pain is when he goes to lift his left leg; This is a spontaneous report from a contactable consumer. This 65-year-old male consumer (patient) reported for himself. A 65-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on 14Feb2021 (at the age of 65-years-old) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Takes no medications. Last physical was over a year ago and put off until he got the COVID-19 Vaccine. He had the first COVID-19 vaccine. Couple days later his left hip started bothering him when he would lift his foot. Thought it was a coincidence. Up until the COVID-19 Vaccine he had no problem. Scheduled for physical in two weeks. Left hip pain: Couple days after first COVID-19 Vaccine. Seemed to get worse and he still has it. Tried different exercises and such. It is very painful. Pain is when he goes to lift his left leg. Pain in left leg is still there. Is just waiting to see. It just didn't go away. Goes for walks on a regular basis. Has been getting around pretty good. Outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
16 year old patient was administered 1st dose of Moderna COVID-19 vaccine even though it is unapproved for those under 18. The patient's mother was present and aware at the time of vaccination. The patient reported nausea/vomiting for one day post-vaccination.
Pt had symptoms of shingles (April 29th) 3 days after 2nd dose (April 24th), pt also had hip surgery April 19th.   Was seen in our office May 12th and tested positive for shingles VZV.
It was 2nd day, I had intense epigastric pain that radiated to my back and lasted about 10 hours, I used over the counter antacids with no effect, and I went to ER at 6 or 7 Am. In the ER they gave me a gastrointestinal cocktail to drink. The ER gave me Carafate prescription for 2 weeks and follow up my primary care physician.
injection site soreness; Injection site redness; This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in an unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site pain and injection site erythema. On an unknown date, the outcome of the injection site pain and injection site erythema were unknown.   It was unknown if the reporter considered the injection site pain and injection site erythema to be related to Shingrix.  Additional case details were reported as follows: The patient identifiers and vaccine lot number/exp. date was not provided by reporter. The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication.  The healthcare professional reported that there were a number of patients in the past who received the first dose of Shingrix and experienced a reaction such as soreness and redness at the injection sites. These patients do not want to receive the 2nd dose of vaccine. The reporter gave permission to follow up. This case had been linked to the case US2019AMR131512, reported by same reporter.
Injection site cellulitis; This is a spontaneous report received from a contactable Physician.  A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) , via an unspecified route of administration from an unspecified date at single dose for immunisation .  The patient medical history  and concomitant medications were not reported.  The patient experienced injection site cellulitis non-serious on an unspecified date with outcome of unknown.  The information on the batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2018499708 Same reporter/product/event, different patient.
This spontaneous report as received from a medical assistant refers to a 2 month old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On 12-JUL-2016, the patient was vaccinated with an expired dose of ROTATEQ lot # L000568, expiration date: 10-JUL-2016, (Strength and dose were not reported), orally. No adverse effect was reported. When a callback was made to the facility attempting to obtain additional information, the staff member who answered stated that the reporting medical assistant no longer worked at the facility. A product quality complaint was not involved. Additional information is not expected because no additional information is available.
The vaccine was administered before the end of the waiting period. About 3 days before the end of the period.
Headache; Muscle ache; Chills; temperature; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), MYALGIA (Muscle ache), CHILLS (Chills) and PYREXIA (temperature) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included Blood thinners and Medication for diabetes for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), MYALGIA (Muscle ache), CHILLS (Chills) and PYREXIA (temperature). At the time of the report, HEADACHE (Headache), MYALGIA (Muscle ache), CHILLS (Chills) and PYREXIA (temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021 at 12:39 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 11-Jan-2021 at 12:39 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 53.58 for dose administered on 11-Jan-2021.  No concomitant medications were reported.  Batch number 041L20A administered on 11-Jan-2021 underwent temperature excursion with temperature of 34 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 05-Jan-2021 and beyond use date for the vial was reported as 04-Feb-2021. Product moved to clinic on 08-Jan-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  No treatment medications were reported.
HEADACHE, FEVER, PAIN AND SWELLING IN THE AREA OF THE VACCINE, CHILLS, MUSCLE PAIN, DIZZINESS, FATIGUE.  I TAKE IBUPROFEN PILL AND REST.
Urticarial rash of upper extremities, anterior and posterior trunk as well as neck. Upper and lower lip swelling with mild facial edema
Pt had redness, swelling and itching at site of injection. What was strange about this reaction is that it developed 3 weeks after the injection while there was no complications prior.
Very sore thigh muscles on both legs. Decentralized soreness on the fronts of the legs.